Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Identifying the Start of Multiple Sclerosis Injury: A Serial DTI Study.
FDA Accepts Biologics License Application For ZINBRYTA (Daclizumab High-Yield Process) For Treatment of MS
Association between parasite infection and immune responses in multiple sclerosis.
B cells and antibodies in multiple sclerosis pathogenesis and therapy.
T cell vaccination benefits relapsing progressive multiple sclerosis patients: a randomized, double-blind clinical trial.
Vitamin D supplementation and monitoring in multiple sclerosis: who, when and wherefore.
Efficacy of glatiramer acetate in neuromyelitis optica spectrum disorder: a multicenter retrospective study.
The Neuroepithelium Disruption Could Generate Autoantibodies against AQP4 and Cause Neuromyelitis Optica and Hydrocephalus.
Lack of response to pulse cyclophosphamide in neuromyelitis optica: evaluation of 7 patients.
The roles of cathelicidin LL-37 in immune defences and novel clinical applications.
ACUTE RETINAL NECROSIS AND IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME IN A NATALIZUMAB-TREATED PATIENT WITH MULTIPLE SCLEROSIS.
Multiple sclerosis and pregnancy: maternal considerations.
Fingolimod (FTY720) stimulates ca(2+)/calcineurin signaling in fission yeast.
XIMINO (minocycline hydrochloride) capsule, extended release [Ranbaxy Laboratories Inc.]
Combined treatment with minocycline and prednisone attenuates experimental autoimmune encephalomyelitis in C57 BL/6 mice.
[Neuromyelitis optica.]
Distinct serum cytokine profiles in neuromyelitis optica and multiple sclerosis.
[Chronically Ill and Unemployed? A Review on Vocational Status in Multiple Sclerosis].
Minocycline up-regulates the expression of brain-derived neurotrophic factor and nerve growth factor in experimental autoimmune encephalomyelitis.
Cannabinoids in the management of difficult to treat pain.
Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease.
What to expect after natalizumab cessation in a real-life setting.
FTY720 is neuroprotective after cuprizone-induced central nervous system demyelination.
Metals and Neurodegeneration.
Multiple neuroprotective mechanisms of minocycline in autoimmune CNS inflammation.

Pages